Patent application number | Description | Published |
20100119411 | APPARATUS AND METHOD TO DELIVER A STERILE, FILLED SYRINGE TO A USER - A stand-alone apparatus to deliver a sterile, filled syringe to a user. The syringe dispenser includes a controller to accept input from the user and to convert the input into an electrical control signal. The syringe dispenser also includes an ozone generator coupled to the controller. The ozone generator generates ozone on demand according to the input from the user. The user may input a parameter for a concentration and/or a volume of ozone. Additionally, the syringe dispenser includes a syringe preparation station coupled to the ozone generator. The syringe preparation station sterilizes the syringe with a first amount of the ozone and fills the syringe with a second amount of the ozone. | 05-13-2010 |
20100307928 | APPARATUS AND METHOD FOR ADMINISTERING A THERAPEUTIC AGENT INTO TISSUE - An apparatus for administering a therapeutic is provided. In various embodiments, the apparatus includes a syringe having a barrel and a plunger and having an ozone generator associated therewith. The generator is initiated and a therapeutic gas is accumulated within the barrel, at which point it can be delivered from the barrel into a target site via a needle, thereby delivering therapeutic effects to that target site. | 12-09-2010 |
20120022438 | APPARATUS FOR ADMINISTERING A THERAPEUTIC AGENT INTO TISSUE USING A NEEDLE AS THE MATERIAL TREATMENT MODUEL - An apparatus for administering a therapeutic is provided. In various embodiments, the apparatus includes a syringe having a barrel and a plunger and having a material treatment module associated with a needle. The material treatment module may be an ozone generator that is initiated such that material containing ozone accumulates within the needle. The material can then be delivered from the barrel into a target site via the needle, thereby delivering therapeutic effects to that target site. | 01-26-2012 |
20120150173 | METHOD FOR IN SITU TREATMENT OF A TISSUE - A method for dehydrating, electro-oxidizing, or electro-reducing a target tissue is described. The method utilizes an electrochemical probe or other device to deliver one or more beneficial agents into the target tissue. Water from the target tissue provides a precursor that may be split by electrolysis to generate the beneficial agent. Alternatively, water is provided from an external source to generate the beneficial agent. The beneficial agent facilitates in situ oxidation and/or reduction of a material within the tissue. One type of beneficial agent is ozone. | 06-14-2012 |
20120312074 | AGGLOMERATION AND CHARGE LOSS SENSOR FOR MEASURING PARTICULATE MATTER - A sensor assembly to measure particulate matter is described. The sensor assembly includes a voltage source, a sensor electrode, a grounded assembly, an integration capacitor, and a current meter. The sensor electrode is coupled to the voltage source to receive a voltage. The sensor electrode is disposed within a directed and controlled exhaust flow within the sensor assembly to facilitate particle agglomeration into particulate matter structures at a surface of the sensor electrode. The grounded assembly is coupled to a ground reference and disposed at a distance from the sensor electrode. The integration capacitor is coupled to a negative side of the voltage source. The integration capacitor is configured to integrate in time current pulses from charge transfers from the sensor electrode of the particulate matter structures. The current meter is coupled to the voltage source to measure an integrated value of current supplied to the voltage source in response to charge transfers from the sensor electrode to the particulate matter structures in the exhaust flow. | 12-13-2012 |
20130219990 | AGGLOMERATION AND CHARGE LOSS SENSOR FOR MEASURING PARTICULATE MATTER - A sensor includes a housing, a central sensor electrode assembly, an insulating member, and a trace. The central sensor electrode assembly is coupled to a supply side of a voltage source. The insulating member is coupled between the housing and the central sensor electrode assembly. The insulating member circumscribes a section of the central sensor electrode assembly. The trace is coupled to the insulating member and circumscribes the section of the central sensor electrode assembly. The trace directs at least a portion of leakage current away from a voltage ground offset on an opposite side of the central sensor electrode assembly. | 08-29-2013 |
20130220801 | APPARATUS ADMINISTERING A THERAPEUTIC AGENT INTO TISSUE - An apparatus for administering a therapeutic is provided. In various embodiments, the apparatus includes an ozone generator for producing therapeutic oxygen-ozone mixture. The generator includes an electrochemical cell configured to communicate with an accumulator having an anode, a cathode and a power supply in electrical communication with the anode and the cathode. The power supply is configured to create an electric current between the anode and the cathode such that water in the electrochemical cell electrolyzes to produce ozone and oxygen at the anode. | 08-29-2013 |
20140144208 | AGGLOMERATION AND CHARGE LOSS SENSOR WITH SEED STRUCTURE FOR MEASURING PARTICULATE MATTER - A sensor includes an electrode and a seed structure. The electrode is configured to measure current due to movement of particulate matter relative to the electrode. The seed structure is deposited on the electrode. The seed structure includes a plurality of elongated members extending outward from the surface of the electrode. The elongated members are configured to promote charge transfer to particles and/or agglomerates of the particulate matter during operation of the sensor. | 05-29-2014 |
20140288484 | APPARATUS AND SYSTEM FOR ADMINISTERING A THERAPEUTIC AGENT INTO TISSUE - An apparatus for administering a therapeutic is provided. In various embodiments, the apparatus includes a syringe having a barrel and a plunger and having an ozone generator associated therewith. The generator is initiated and a therapeutic gas is accumulated within the barrel, at which point it can be delivered from the barrel into a target site via a needle, thereby delivering therapeutic effects to that target site. | 09-25-2014 |